Literature DB >> 29441462

Up-regulation of miR-340-5p promotes progression of thyroid cancer by inhibiting BMP4.

P Zhao1, W Ma1, Z Hu1, Y Zhang1, S Zhang2, Y Wang3.   

Abstract

PURPOSE: The incidence of thyroid cancer is increasing and the proliferation of thyroid cancer cells is incompletely understood. microRNAs may play key roles in thyroid cancer progression.
METHODS: We analyzed miR-340-5p in thyroid cancer tissue and normal tissue, and using informatics to predict its target. Cell lines and a mouse model were used to study the role of miR-340-5p in cancer proliferation.
RESULTS: Overexpression of miR-340-5p was found in thyroid cancer specimens. Tumors with higher pathological grade had higher levels of miR-340-5p. Overexpression of miR-340-5p significantly enhanced cell viability and colony formation. Treatment of anti-miR-340-5p, however, showed opposite alterations. We predicted that bone morphogenetic protein 4 (BMP4) is a possible target, and found a negative correlation between miR-340-5p and BMP4 levels in thyroid cancer tissue. miR-340-5p reduced BMP4 expression. BMP4 overexpression attenuated the effects of miR-340-5p in cell viability and colony formation. In addition, using a xenograft mouse model we proved that anti-miR-340-5p was able to inhibit tumor growth.
CONCLUSIONS: miR-340-5p promotes thyroid cancer proliferation by inhibiting BMP4. Anti-miR-340-5p can be a promising strategy to control thyroid cancer.

Entities:  

Keywords:  Bone morphogenetic protein 4; Cell proliferation; Colony formation; MicroRNAs; Thyroid carcinoma; miR340-5p

Mesh:

Substances:

Year:  2018        PMID: 29441462     DOI: 10.1007/s40618-018-0848-6

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  25 in total

1.  Expression of BMP-4 in papillary thyroid carcinoma and its correlation with tumor invasion and progression.

Authors:  Xiaomei Meng; Peng Zhu; Ning Li; Jinchen Hu; Shaoguang Wang; Shuguang Pang; Jiahui Wang
Journal:  Pathol Res Pract       Date:  2017-01-17       Impact factor: 3.250

2.  The Adenosine A1 Receptor Antagonist DPCPX Inhibits Tumor Progression via the ERK/JNK Pathway in Renal Cell Carcinoma.

Authors:  Yihong Zhou; Liang Tong; Xi Chu; Fei Deng; Jin Tang; Yuxin Tang; Yingbo Dai
Journal:  Cell Physiol Biochem       Date:  2017-09-27

3.  Oncogenic KRAS regulates BMP4 expression in colon cancer cell lines.

Authors:  Eva-Maria Duerr; Yusuke Mizukami; Kentaro Moriichi; Manish Gala; Won-Seok Jo; Hirotoshi Kikuchi; Ramnik J Xavier; Daniel C Chung
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-01       Impact factor: 4.052

4.  Cancer Statistics, 2017.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2017-01-05       Impact factor: 508.702

Review 5.  MicroRNA therapeutics: towards a new era for the management of cancer and other diseases.

Authors:  Rajesha Rupaimoole; Frank J Slack
Journal:  Nat Rev Drug Discov       Date:  2017-02-17       Impact factor: 84.694

6.  Bone morphogenetic protein-2 and -4 play tumor suppressive roles in human diffuse-type gastric carcinoma.

Authors:  Yo-taro Shirai; Shogo Ehata; Masakazu Yashiro; Kazuyoshi Yanagihara; Kosei Hirakawa; Kohei Miyazono
Journal:  Am J Pathol       Date:  2011-10-11       Impact factor: 4.307

7.  MicroRNA (miRNA) in cancer.

Authors:  Kaladhar B Reddy
Journal:  Cancer Cell Int       Date:  2015-04-02       Impact factor: 5.722

8.  Family of microRNA-146 Regulates RARβ in Papillary Thyroid Carcinoma.

Authors:  Agnieszka Anna Czajka; Anna Wójcicka; Anna Kubiak; Marta Kotlarek; Elwira Bakuła-Zalewska; Łukasz Koperski; Wiesław Wiechno; Krystian Jażdżewski
Journal:  PLoS One       Date:  2016-03-24       Impact factor: 3.240

9.  TNF-α mRNA is negatively regulated by microRNA-181a-5p in maturation of dendritic cells induced by high mobility group box-1 protein.

Authors:  Jing Zhu; Fu-Li Wang; Hai-Bin Wang; Ning Dong; Xiao-Mei Zhu; Yao Wu; Yong-Tao Wang; Yong-Ming Yao
Journal:  Sci Rep       Date:  2017-09-25       Impact factor: 4.379

10.  MicroRNA-340-5p modulates cisplatin resistance by targeting LPAATβ in osteosarcoma.

Authors:  L Song; P Duan; Y Gan; P Li; C Zhao; J Xu; Z Zhang; Q Zhou
Journal:  Braz J Med Biol Res       Date:  2017-04-20       Impact factor: 2.590

View more
  10 in total

1.  LncRNA RUSC1-AS1 contributes to the progression of hepatocellular carcinoma cells by modulating miR-340-5p/CREB1 axis.

Authors:  Chunjiang Liu; Liming Tang; Miaojun Xu; Yuting Lin; Jingfu Shen; Liang Zhou; Lichen Ho; Jinjing Lu; Xiaoming Ai
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

2.  Suppression of microRNA 124-3p and microRNA 340-5p ameliorates retinoic acid-induced cleft palate in mice.

Authors:  Hiroki Yoshioka; Akiko Suzuki; Chihiro Iwaya; Junichi Iwata
Journal:  Development       Date:  2022-05-03       Impact factor: 6.862

3.  Effects of miR‑340 overexpression and knockdown on the proliferation and metastasis of NSCLC cell lines.

Authors:  Xidan Zhu; Gang Tian; Jing Quan; Peng He; Jinbo Liu
Journal:  Int J Mol Med       Date:  2019-05-29       Impact factor: 4.101

4.  miR‑592 acts as an oncogene and promotes medullary thyroid cancer tumorigenesis by targeting cyclin‑dependent kinase 8.

Authors:  Ting Liu; Jingjing Meng; Yu Zhang
Journal:  Mol Med Rep       Date:  2020-07-30       Impact factor: 2.952

5.  Hypoxic tumour cell-derived exosomal miR-340-5p promotes radioresistance of oesophageal squamous cell carcinoma via KLF10.

Authors:  Fangyu Chen; Bing Xu; Jie Li; Xi Yang; Junjie Gu; Xijuan Yao; Xinchen Sun
Journal:  J Exp Clin Cancer Res       Date:  2021-01-23

6.  LncRNA LINC00857 strengthens the malignancy behaviors of pancreatic adenocarcinoma cells by serving as a competing endogenous RNA for miR-340-5p to upregulate TGFA expression.

Authors:  Tingfu Li; Hongbo Zhao; Hua Zhou; Tingting Geng
Journal:  PLoS One       Date:  2021-03-04       Impact factor: 3.240

7.  Targeting FHL2-E-cadherin axis by miR-340-5p attenuates colon cancer cell migration and invasion.

Authors:  Anwar Algaber; Raed Madhi; Avin Hawez; Carl-Fredrik Rönnow; Milladur Rahman
Journal:  Oncol Lett       Date:  2021-07-03       Impact factor: 2.967

Review 8.  miR-340: A multifunctional role in human malignant diseases.

Authors:  Zheng Huang; Yesha Xu; Maoping Wan; Xixi Zeng; Jianmin Wu
Journal:  Int J Biol Sci       Date:  2021-01-01       Impact factor: 6.580

9.  miR-340 Promotes Retinoblastoma Cell Proliferation, Migration and Invasion Through Targeting WIF1.

Authors:  Kun Li; Fengmei Han; Yanping Wu; Xue Wang
Journal:  Onco Targets Ther       Date:  2021-06-04       Impact factor: 4.147

10.  LncRNA RUSC1-AS1 promotes osteosarcoma progression through regulating the miR-340-5p and PI3K/AKT pathway.

Authors:  Chang-Jun Tong; Qing-Chun Deng; Di-Jun Ou; Xia Long; He Liu; Kang Huang
Journal:  Aging (Albany NY)       Date:  2021-05-28       Impact factor: 5.682

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.